2022 - Research.com Best Female Scientist Award
Her primary areas of study are Parkinson's disease, Disease, Pathology, Substantia nigra and Internal medicine. Her studies in Parkinson's disease integrate themes in fields like Psychiatry, Dementia, Pediatrics and Prospective cohort study. Her study in Disease is interdisciplinary in nature, drawing from both Physical therapy, Neuroscience and Rating scale.
The various areas that Daniela Berg examines in her Pathology study include Echogenicity, Central nervous system disease, Transcranial Doppler, Magnetic resonance imaging and Neurology. Her Substantia nigra research also works with subjects such as
Daniela Berg focuses on Parkinson's disease, Disease, Internal medicine, Pathology and Substantia nigra. Her work deals with themes such as Physical medicine and rehabilitation, Dementia, Physical therapy and Neurology, Neuroscience, which intersect with Parkinson's disease. Her Disease research includes elements of Biomarker, Psychiatry, Depression and Cohort.
Her research in Internal medicine intersects with topics in Gastroenterology, Endocrinology, Oncology and Cardiology. Her Pathology research incorporates themes from Magnetic resonance imaging and Central nervous system disease. Her biological study spans a wide range of topics, including Echogenicity, Transcranial Doppler and Degenerative disease.
Daniela Berg mainly investigates Parkinson's disease, Disease, Internal medicine, Physical medicine and rehabilitation and Cognition. In her works, Daniela Berg performs multidisciplinary study on Parkinson's disease and In patient. Daniela Berg has included themes like Penetrance, Neurology, Neuroscience and Cohort in her Disease study.
In Internal medicine, Daniela Berg works on issues like Endocrinology, which are connected to Cerebrospinal fluid. The study incorporates disciplines such as Levodopa and Cognitive impairment in addition to Physical medicine and rehabilitation. Daniela Berg combines subjects such as Physical therapy and Audiology with her study of Cognition.
The scientist’s investigation covers issues in Parkinson's disease, Disease, Internal medicine, Physical medicine and rehabilitation and Atrophy. Her work deals with themes such as Longitudinal study, Cognition, Prospective cohort study, Movement disorders and Confounding, which intersect with Parkinson's disease. Her Disease study combines topics in areas such as Biomarker and Neuroscience.
Her research integrates issues of Penetrance and Oncology in her study of Internal medicine. When carried out as part of a general Physical medicine and rehabilitation research project, her work on Gait and Balance is frequently linked to work in In patient, therefore connecting diverse disciplines of study. The Atrophy study combines topics in areas such as Amyloid beta, MEDLINE, Treatment outcome, Consensus criteria and Pediatrics.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
MDS clinical diagnostic criteria for Parkinson's disease
Ronald B. Postuma;Daniela Berg;Matthew Stern;Werner Poewe.
Movement Disorders (2015)
Genome-wide association study reveals genetic risk underlying Parkinson's disease
Javier Simón-Sánchez;Claudia Schulte;Jose M Bras;Jose M Bras;Manu Sharma.
Nature Genetics (2009)
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
Ellen Sidransky;Michael A. Nalls;Jan O. Aasly;Judith Aharon-Peretz.
The New England Journal of Medicine (2009)
The Parkinson Progression Marker Initiative (PPMI)
Kenneth Marek;Danna Jennings;Shirley Lasch;Andrew Siderowf.
Progress in Neurobiology (2011)
MDS research criteria for prodromal Parkinson's disease
Daniela Berg;Ronald B. Postuma;Charles H. Adler;Bastiaan R. Bloem.
Movement Disorders (2015)
Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease
Karsten M. Strauss;L. Miguel Martins;Helene Plun-Favreau;Frank P. Marx.
Human Molecular Genetics (2005)
Loss-of-Function of Human PINK1 Results in Mitochondrial Pathology and Can Be Rescued by Parkin
Nicole Exner;Bettina Treske;Dominik Paquet;Kira Holmström.
The Journal of Neuroscience (2007)
Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: the PDGene database.
Christina M. Lill;Johannes T. Roehr;Johannes T. Roehr;Matthew B. McQueen;Fotini K. Kavvoura;Fotini K. Kavvoura;Fotini K. Kavvoura.
PLOS Genetics (2012)
Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome.
Alexander Zimprich;Monika Grabowski;Friedrich Asmus;Markus Naumann.
Nature Genetics (2001)
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy
J.A. Obeso;M. Stamelou;M. Stamelou;C.G. Goetz;W. Poewe.
Movement Disorders (2017)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Tübingen
University of Luxembourg
Kiel University
University of Tübingen
Innsbruck Medical University
McGill University
Philipp University of Marburg
University of Göttingen
University of Duisburg-Essen
University of Lübeck
Princeton University
Shandong University
RIKEN
Toyohashi University of Technology
Northwestern University
University of Basel
Institut Pasteur
Norwegian Polar Institute
Hokkaido University
University of Nottingham
University of Oxford
Hiroshima University
University of Tsukuba
National Oceanic and Atmospheric Administration
University of California, San Francisco
University of Hong Kong